Apple Inc said it expects supply constraints would cost US$4 billion to US$8 billion in revenue this quarter, a warning that sent the shares tumbling and cast a pall on record-setting results that the company just reported.
COVID-19 pandemic restrictions that have been implemented China in the past few weeks will take a toll on the April-to-June quarter, Apple said during a conference call on Thursday.
The fiscal second quarter’s sales and profit had topped analysts’ estimates, fueled by strong demand for iPhones and digital services, and the company announced US$90 billion in new stock buybacks.
Photo: AFP
The outlook renewed fears that supply-chain woes would continue to roil the tech industry following a short-lived recovery from pandemic struggles.
Companies ranging from Microsoft Corp to Texas Instruments Inc have already said that China’s COVID-19 lockdowns would crimp sales and make it harder to produce products such as the Xbox.
The administration of Chinese President Xi Jinping (習近平) has embraced a “COVID-19 zero” policy, with the effects of restrictions reverberating through the world’s supply lines.
Chip shortages and the Ukraine war also are causing disruptions, Apple chief executive officer Tim Cook said during the call.
“We are not immune to these challenges, but we have great confidence in our teams, and our products and services, and in our strategy,” Cook said.
Apple shares tumbled as much as 6.2 percent to US$153.50 in late trading after the remarks.
The stock had already fallen about 7.8 percent this year before the company gave the warning, hurt by a broader tech downturn. Apple had gained 34 percent last year, its third straight year of increases.
The latest supply woes did not begin until the very end of last month, so last quarter was not affected, Apple said.
Sales rose 8.6 percent to US$97.3 billion in the period, a record for a non-holiday quarter, Apple said earlier on Thursday.
Analysts had projected US$94 billion on average.
Profit came in at US$1.52 per share, compared with a prediction of US$1.42, initially sending the shares up in late trading.
Apple had previously said the January-to-March quarter would be a record, although its growth rate would decelerate for the overall business and its services segment.
The company’s fourth quarter last year was a blowout sales period, exceeding Wall Street estimates with an all-time revenue high of nearly US$124 billion.
Following its usual pattern, Apple used the company’s second-quarter report to increase its dividend and boost stock repurchases. The dividend is to grow 5 percent to US$0.23 per share.
The Cupertino, California-based company said that China’s COVID-19 restrictions also have affected demand in that country, but that broader demand has been strong.
It said that it is contending with increasing inflation and a pullout from Russia following that country’s invasion of Ukraine.
Analysts are projecting third-quarter revenue of about US$86 billion.
In the fiscal second quarter, which ended on March 26, Apple generated US$50.6 billion from the iPhone, its biggest source of revenue. That compared with an average estimate of US$49.2 billion.
The company launched the low-cost iPhone SE last month, contributing to sales in the first quarter.
However, the flagship iPhone 13 might have been less of a draw than the previous year’s iPhone 12, which was more of a dramatic update.
The iPhone 13 retained the earlier model’s design, with some minor upgrades that focused on camera improvements.
The Mac continued its resurgence, generating revenue of US$10.4 billion in the quarter.
Apple launched the high-powered Mac Studio desktop in the quarter, but many orders of that machine have been delayed due to supply chain shortages, customization time and high demand.
The strong Mac sales are likely primarily due to the new MacBook Pros.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained